To determine the cytotoxic effects and inhibitory activity of RB in GBM cells, we treated P3#GBM, U251 and A172 cells with RB at 2 or 4 μM concentrations for 24, 48 and 72 h in vitro. The gene discussed is RB1; the disease is glioblastoma.